Skip to main content
Premium Trial:

Request an Annual Quote

Novavax Anticipates Authorization

SARS-CoV-2 vaccine maker Novavax expects to receive US Food and Drug Administration authorization for its shot next month, CNBC reports.

Last year, Novavax reported that its vaccine was more than 90 percent effective in preventing COVID-19, but the company pushed its timeline for seeking authorization from May 2021 to third quarter 2021 and then to the fourth quarter. According to CNBC, Novavax submitted its application to FDA in January, and an FDA advisory committee is meeting next month to review it.

Chief Commercial Officer John Trizzino said during a Bank of America conference that he is hopeful, according to CNBC. "We're fully expecting based upon our submission, based upon all the back and forth questions that have been asked and answered, based upon the inspection at Serum, to come out of that meeting with a recommendation for emergency use authorization," he added, referring to an inspection at teh company's manufacturing partner Serum Institute of India, as CNBC notes.

The European Union authorized Novavax's SARS-CoV-2 vaccine for people 18 years old and older in December.

Filed under

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.